Cargando…
Short overview on the current standard of treatment in newly diagnosed multiple myeloma
The treatment of newly diagnosed multiple myeloma has changed dramatically over the past 20 years, from near uniform application of chemotherapy to a patient performance status- and risk-based approach. Furthermore, initiation of treatment criteria have evolved from a pure end-organ damage-based def...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Vienna
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862912/ https://www.ncbi.nlm.nih.gov/pubmed/29606980 http://dx.doi.org/10.1007/s12254-018-0383-3 |